Wyeth gets BeneFIX enhancement approval |
|
|
|
Published
:
Mon, 26 Mar 2007 17:16
|
MADISON, N.J. (AP) - Drug developer Wyeth said Monday the Food and Drug Administration approved enhancements for its hemophilia medicine BeneFIX.The drug is a clotting substitute for patients with hemophilia B. The new approvals are for a lower amount of dilutive to administer the drug and a new needleless preparation process. The FDA also approved a 2,000 international unit-dosage strength vial, according to the companyWyeth said it expects to begin offering the new enhancements in the middle of 2007.Shares of Wyeth fell 45 cents to $50.10 on the New York Stock Exchange in midday trading.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Woman wins $3 million in Prempro case 